1. 195. Use of botulinum toxin in nondystonic disorders. (January 2015) Authors: Truong, Daniel Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasm. (January 2016) Authors: Truong, Daniel; Fezza, John; Burns, John; Woodward, Julie; Hedges, Thomas; Verma, Amit Journal: Parkinsonism & related disorders Issue: Volume 22(2016)Supplement 2 Page Start: e138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase 3, Open-Label, Multicenter Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia. (July 2022) Authors: Slawek, Jaroslaw; McAllister, Peter; Paus, Sebastian; Truong, Daniel; Gross, Todd M.; Rubio, Roman G.; Kesslak, Pat; Vitarella, Domenico Journal: Toxicon Issue: Volume 214(2022)Supplement 1 Page Start: S50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions. (2021) Authors: Lew, Mark F.; Hauser, Robert A.; Isaacson, Stuart H.; Truong, Daniel; Patel, Atul T.; Brashear, Allison; Ondo, William; Maisonobe, Pascal; Dashtipour, Khashayar; Bahroo, Laxman; Wietek, Stefan Journal: Clinical parkinsonism & related disorders Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AbobotulinumtoxinA using 2 mL dilution maintains durable functional improvements across multiple treatment cycles. (December 2018) Authors: Dashtipour, Khashayar; Bahroo, Laxman; Truong, Daniel; Trosch, Richard; Maisonobe, Pascal; Otto, James F. Journal: Toxicon Issue: Volume 156(2018)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Adapting to post-COVID19 research in Parkinson's disease: Lessons from a multinational experience. (January 2021) Authors: Tan, Eng-King; Albanese, Alberto; Chaudhuri, KRay; Lim, Shen-Yang; Oey, Nicodemus Edrick; Shan Chan, Christine Hui; Wu, Yun-Cheng; Jeon, Beomseok; Truong, Daniel; Poewe, Werner; Pal, Pramod Kumar; Tan, Louis; Opal, Puneet; Colosimo, Carlo; Jinnah, H.A.; Cardoso, Francisco Journal: Parkinsonism & related disorders Issue: Volume 82(2021) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study). Issue 6 (4th February 2015) Authors: Pahwa, Rajesh; Tanner, Caroline M.; Hauser, Robert A.; Sethi, Kapil; Isaacson, Stuart; Truong, Daniel; Struck, Lynn; Ruby, April E.; McClure, Natalie L.; Went, Gregory T.; Stempien, Mary Jean Journal: Movement disorders Issue: Volume 30:Issue 6(2015) Page Start: 788 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. An SI-traceable multilateration coordinate measurement system with half the uncertainty of a laser tracker. (1st June 2023) Authors: Guillory, Joffray; Truong, Daniel; Wallerand, Jean-Pierre; Svantesson, Claes-Göran; Herbertsson, Magnus; Bergstrand, Sten Journal: Measurement science & technology Issue: Volume 34:Number 6(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. ANCHOR‐CD (AbobotulinumtoxinA Neurotoxin: Clinical and Health Economics Outcomes Registry in Cervical Dystonia): An Economic Evaluation of the Reimbursement Cost of Dysport® Treatment for Non‐Naive Patients. Issue 9 (17th September 2013) Authors: Marchese, Dominic; Truong, Daniel; Mari, Zoltan; Chen, Jack; Cetnarowski, Wes; Trosch, Richard Journal: PM&R Issue: Volume 5:Issue 9(2013)Supplement Page Start: S148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. ANCHOR‐CD (AbobotulinumtoxinA Neurotoxin: Clinical and Health Economics Outcomes Registry in Cervical Dystonia): A Multicenter, Observational Study of Dysport® (AbobotulinumtoxinA) in Cervical Dystonia: Baseline Data and Cycle One Efficacy Data. Issue 9 (17th September 2013) Authors: Polukhin, Elena L.; Jozefczyk, Patricia; Truong, Daniel; Espay, Alberto J.; Abbott, Chandra; Comella, Cynthia; Marchese, Dominic; Trosch, Richard Journal: PM&R Issue: Volume 5:Issue 9(2013)Supplement Page Start: S149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗